ARCHIVES

“Tone” Of Statement Lacks Balance, Klausner Says

This article is from The Cancer Letter archive.

Vol. 23 No. 04 | January 31, 1997

Download PDF Visit The Full Archive

Related Articles

Phase III Trial Data: Lenvatinib Extends PFS by Over 14 Months

June 27, 2014

Aromasin Approved By FDA For ER+ Early Breast Cancer

October 28, 2005

NCI Grants Funding: New Funds Moved Into R01s, other Extramural Priorities

December 12, 1997

Questions Raised By Committee Kills Still Not Resolved

July 29, 1977

In Brief: Radiologists Elect Officers, Award Medals; FDA Advisors Okay Test For Breast Cancer

September 29, 1995

In Brief: Resolution Seeks Two-Fold Increase For NIH; Hartwell Named President At Fred Hutchinson

January 31, 1997